Form 8-K - Current report:
SEC Accession No. 0001140361-25-017615
Filing Date
2025-05-07
Accepted
2025-05-07 07:33:58
Documents
18
Period of Report
2025-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20048471_8k.htm   iXBRL 8-K 34435
2 EXHIBIT 99.1 ef20048471_ex99-1.htm EX-99.1 208412
7 image00002.jpg GRAPHIC 3255
8 image00003.jpg GRAPHIC 3266
9 image00004.jpg GRAPHIC 3476
  Complete submission text file 0001140361-25-017615.txt   459034

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA imcr-20250507.xsd EX-101.SCH 4454
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imcr-20250507_def.xml EX-101.DEF 17585
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE imcr-20250507_lab.xml EX-101.LAB 26483
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imcr-20250507_pre.xml EX-101.PRE 19770
20 EXTRACTED XBRL INSTANCE DOCUMENT ef20048471_8k_htm.xml XML 6340
Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Filer) CIK: 0001671927 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39992 | Film No.: 25919303
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)